Fever is a common clinical symptom, often indicative of an underlying pathological condition. As healthcare professionals, it is crucial to understand the mechanisms, evaluation, and management strategies of fever.
Fevers are typically a result of the body's immune response to infection or inflammation. Pyrogens stimulate the hypothalamus to increase the body's set point temperature, leading to fever. It's important to note, however, that non-infectious diseases, certain drugs, and malignancies can also trigger a febrile response.
A thorough history and physical examination are essential in fever evaluation. Key aspects include travel history, exposure to infectious diseases, medication history, and presence of immunosuppression. Laboratory investigations, including complete blood count, cultures, and inflammatory markers, can provide valuable insights.
Management primarily focuses on treating the underlying cause. Antipyretics, like acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), can be used for symptomatic relief. However, their use should be judicious, as fever plays a crucial role in host defense mechanisms. In cases of persistently high fever or febrile patients with significant comorbidities, hospitalization may be necessary.
Children and immunocompromised individuals require special attention, as fever might indicate a severe infection. In neonates, even a slight elevation in temperature warrants immediate evaluation. Similarly, in immunocompromised patients, fever could be the only sign of a potentially life-threatening infection.
Managing fever in clinical practice requires a comprehensive understanding of its mechanisms, evaluation techniques, and appropriate management strategies. By adopting a systematic approach, healthcare professionals can ensure effective patient care and optimize outcomes.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation